癌症个体化治疗设计的微扰分析
Infinitesimal Perturbation Analysis for Personalized Cancer Therapy Design
摘要:
我们使用一个随机混合自动机(SHA)模型的前列腺癌的演变间歇性雄激素抑制(IAS)研究治疗设计的阈值为基础的政策。IAS是目前晚期前列腺癌最广泛使用的治疗方法之一。接受IAS的患者以交替方式接受治疗周期(雄激素剥夺形式)和停药期。IAS中的主要挑战之一是最佳地设计治疗方案,即,以确定何时停止和重新开始雄激素抑制。经常监测患者血清中前列腺特异性抗原(PSA)的水平,以确定患者何时停止治疗以及何时恢复治疗。我们提出的基于阈值的策略由PSA门限值的下限和上限参数化,并且与结合治疗成功的临床相关测量的成本度量相关联。使用无穷小扰动分析(IPA),我们得到无偏梯度估计的成本度量相对于可控的PSA门限值的基础上的实际数据,并显示这些估计可以用来自适应地调整可控参数,以改善治疗效果的基础上定义的成本度量。
英文摘要:
We use a Stochastic Hybrid Automaton (SHA) model of prostate cancer evolution under intermittent androgen suppression (IAS) to study a threshold-based policy for therapy design. IAS is currently one of the most widely used treatments for advanced prostate cancer. Patients undergoing IAS are submitted to cycles of treatment (in the form of androgen deprivation) and off-treatment periods in an alternating manner. One of the main challenges in IAS is to optimally design a therapy scheme, i.e., to determine when to discontinue and recommence androgen suppression. The level of prostate specific antigen (PSA) in a patient's serum is frequently monitored to determine when the patient will be taken off therapy and when therapy will resume. The threshold-based policy we propose is parameterized by lower and upper PSA threshold values and is associated with a cost metric that combines clinically relevant measures of therapy success. Using Infinitesimal Perturbation Analysis (IPA), we derive unbiased gradient estimators of this cost metric with respect to the controllable PSA threshold values based on actual data and show how these estimators can be used to adaptively adjust controllable parameters so as to improve therapy outcomes based on the cost metric defined.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。